EU Antibiotics Market, by Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitor, RNA Synthesis Inhibitors and Mycolic Acid Inhibitors) and by Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolides, Carbapenem, Aminoglycosides, Sulphonamides and Others) Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138173
- Pages: 200
-
Format:
Report Overview
The EU Antibiotics market size stood at around USD $11.56 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
Antibiotics are a class of drugs employed mainly against bacterial infections. They are ineffective against viral infections and most other infections. Antibiotics either kill microorganisms or stop them from reproducing, allowing the body's natural defenses to eliminate them
Market Drivers
The rising numbers of patients who are suffering from infectious diseases lead to the growth of the antibiotics market. Many pharmaceuticals companies are conducting on-going trials that are likely to propel the growth of the market
1. EU Antibiotics Market Overview
A. Market Size
2. EU Antibiotics Market Growth Drivers
I. The rising numbers of patients who are suffering from infectious diseases
II. Many pharmaceuticals companies are conducting on-going trials
3. EU Antibiotics Market Segmentation.
A. By Action Mechanism
I. Cell Wall Synthesis Inhibitors
II. Protein Synthesis Inhibitors
III. DNA Synthesis Inhibitors
IV. RNA Synthesis Inhibitors
V. Mycolic Acid Inhibitors
B. By Drug Class
I. Cephalosporin
II. Penicillin
III. Fluoroquinolone
IV. Macrolides
V. Carbapenem
VI. Aminoglycosides
VII. Sulfonamides
VIII. Others
4. EU Antibiotics Market Major Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Glaxo Smith Kline Company overview, Product & Services, Strategies & Financials
B. Johnson & Johnsons Company overview, Product & Services, Strategies & Financials
C. Merck Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Market Opportunities and Future Trends
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
